Five-year economic and quality of life outcomes favor PCI with zotarolimus stents over CABG in 3-vessel CADFive-year follow-up reveals lower costs and better employment for PCI over surgery in complex heart disease

Many people with severe heart disease face a hard choice. They can have open-heart surgery to bypass blocked arteries or they can get stents placed to open the vessels. This decision is often made by doctors, but patients deserve to know the long-term picture. A new study looks at this choice for people with three-vessel coronary artery disease. This condition means blockages in all three main arteries feeding the heart. It is a serious form of heart disease that requires careful treatment. This research followed patients for five years to see who spent less money and who felt better. The results show that stent treatment often wins on cost and daily life. This matters because healthcare costs are rising and patients want to return to work. The study helps families plan for the future without fear of hidden bills. It also helps doctors explain options clearly to their patients. The findings come from a large group of people who faced this exact dilemma. Understanding the numbers behind these choices can reduce anxiety. Patients can make decisions based on facts rather than fear. The study shows that stents are a strong option for many. It does not mean surgery is useless, but it highlights the value of stents. The data comes from a randomized trial. This means patients were assigned to one group or the other by chance. This method removes bias and gives a fair comparison. The results are based on real-world outcomes over a long time. This is important because heart disease is a lifelong condition. Short-term fixes are not enough. We need to know what happens years later. This study answers that question with clear evidence. It shows that stents save money and improve life quality. The numbers speak for themselves. Patients can use this information to talk to their doctors. They can ask about the long-term financial impact of their treatment. This knowledge empowers them to take control of their health journey. The study also looked at how quickly patients felt better. Those with stents improved faster. This speed matters for getting back to normal life. It also affects how long people stay employed. Many patients worry about losing their jobs due to heart issues. This study shows stents help keep people working longer. The financial benefits are also clear. Surgery costs more over five years. This is not just about the hospital bill. It includes follow-up care and recovery time. Stents reduce the overall burden on the family budget. The study used a standard measure called QALYs. This stands for quality-adjusted life years. It combines how long you live with how well you feel. The scores were nearly the same for both groups. This means both treatments extend life and improve feeling. However, the cost difference is significant. The study also checked safety. No major safety issues were reported. This gives confidence to patients considering stents. The research team was careful to avoid hype. They presented the data honestly. The conclusion is that stents offer a valuable path forward. They balance cost and quality of life well. Patients should discuss these options with their care team. The goal is to find the best path for each person. This study provides a solid foundation for that conversation.